PRELUDE CAPITAL MANAGEMENT, LLC

Position in WHWK — Whitehawk Therapeutics, Inc.

CIK 1387508 NEW YORK, NY

Position in WHWK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$35,476

-$10,010 QoQ

Shares Held

10,283

-45.3% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $75,046,663 across 96 Biotechnology names. WHWK ranks #86 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc.	98,849	$11,349,842
2	FOLD	AMICUS THERAPEUTICS, INC.	639,885	$9,252,737
3	PGEN	Precigen, Inc.	1,270,053	$4,915,105
4	APLS	Apellis Pharmaceuticals, Inc.	111,468	$4,484,357
5	ROIV	Roivant Sciences Ltd.	111,593	$3,091,126
6	PRAX	Praxis Precision Medicines, Inc.	9,064	$2,920,330
7	TERN	Terns Pharmaceuticals, Inc.	54,825	$2,890,374
8	COGT	Cogent Biosciences, Inc.	64,222	$2,471,904

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$35,476	10,283	-45.3%	Shares	Other	2026-05-15
2025-12-31	$45,486	18,796	+84.3%	Shares	Other	2026-02-17
2025-03-31	$18,150	10,197	-20.9%	Shares	Other	2025-05-15
2024-12-31	$40,690	12,897	-27.5%	Shares	Other	2025-02-14
2024-09-30	$36,661	17,797	-50.8%	Shares	Other	2024-11-14
2024-06-30	$52,847	36,197	-1.1%	Shares	Other	2024-08-14
2024-03-31	$85,636	36,597	+38.6%	Shares	Other	2024-05-15
2023-12-31	$53,321	26,397	+20.6%	Shares	Other	2024-02-14
2023-09-30	$105,981	21,897	+97.7%	Shares	Other	2023-11-14
2023-06-30	$75,746	11,074	—	Shares	Other	2023-08-14
No filing history on record for this holder in this stock.